iBio (IBIO) Non-Current Assets (2009 - 2026)
iBio's Non-Current Assets was $6.89 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 48.8% from $13.46 million a year earlier and down 19.3% from the prior quarter.
iBio (IBIO) Non-Current Assets (2009 - 2026) Analysis & Trends
From fiscal Q4 2011 onward, iBio has reported Non-Current Assets for 61 quarters.
- Non-Current Assets shows a five-year compound annual growth rate of -30.5% (FY2021 to FY2026).
- In earlier fiscal years, Non-Current Assets was $13.46 million in FY2025 (+3.1%), $13.06 million in FY2024 (-12.6%), $14.95 million in FY2023 (-72.5%) and $54.34 million in FY2022 (+28.2%).
- The fiscal Q4 2026 figure marks the lowest quarterly Non-Current Assets since fiscal Q2 2016.
- Compared with a year earlier, Non-Current Assets has declined for three straight quarters, with an average decline of 15.0% over the last eight quarters.
- The best year-over-year quarter for Non-Current Assets over five years was fiscal Q2 2022 (growth of 70.8%); the worst was fiscal Q2 2023 (a decline of 77.0%).
- Per Business Quant data, IBIO's Non-Current Assets in the three fiscal quarters before Q4 2026 was $8.53 million (Q3 2026), $10.99 million (Q2 2026) and $13.36 million (Q1 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | iBio | 118.23 Mn | -174.02 Mn | - | 7.41 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.41 Mn |
| Jun 30, 2026 | 6.89 Mn |
| Mar 31, 2026 | 8.53 Mn |
| Dec 31, 2025 | 10.99 Mn |
| Sep 30, 2025 | 13.36 Mn |
| Jun 30, 2025 | 13.46 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Dec 31, 2024 | 13.40 Mn |
| Sep 30, 2024 | 12.81 Mn |
| Jun 30, 2024 | 13.06 Mn |
| Mar 31, 2024 | 14.02 Mn |
| Dec 31, 2023 | 14.32 Mn |
| Sep 30, 2023 | 14.66 Mn |
| Jun 30, 2023 | 14.95 Mn |
| Mar 31, 2023 | 17.29 Mn |
| Dec 31, 2022 | 13.57 Mn |
| Sep 30, 2022 | 21.00 Mn |
| Jun 30, 2022 | 54.34 Mn |
| Mar 31, 2022 | 55.05 Mn |
| Dec 31, 2021 | 58.95 Mn |
iBio Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=IBIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();